Kristie Neo

Senior Writer, Venture Capital & Unicorns​
Email: kristie@dealstreetasia.com

SG Digest: Gobi Partners re-invests in WaveOptics; Umitron gets funding

Gobi Partners re-invests in UK augmented reality startup, WaveOptics while Spiking sells out its first tranche of initial token offering in the first three hours.


Spiral Ventures targets final close of first SEA & India fund in mid-2019

The venture capital firm is seeking to raise between $30 million and $50 million for the Southeast Asia and India fund.


SG’s Visvires New Protein invests in Israeli aquaculture startup ViAqua

ViAqua plans to use the funds to perform research and development, and optimise its final product before bringing it to market.


Singapore: TNB Aura hits final close for $22.7m SEA venture fund

Singapore-based venture capital firm, TNB Aura has secured the final close of its first $22.7 million (S$31.1 million) venture fund targeting Southeast Asia.

According to an official statement, the oversubscribed fund was backed by institutional investors, regional corporations, family offices and high net worth individuals. TNB Aura was initially targeting a hard close of $22.5 million (S$30 million).


SG Digest: Gogoprint buys Indonesia’s Prinzio; 4FINGERS acquires Mex Out

Indonesian printing startup Prinzio is backed by East Ventures and was founded by Riky Tenggara, a former Lazada and Rocket Internet executive, in 2016


Singapore’s ICT Fund confirms plans to launch $100m second vehicle in 2019

ICT Fund II will issue average check sizes of $10 million and invest in 12-14 enterprise technology firms across Southeast Asia. 


Singapore’s Jungle Ventures nears first close of $200m third fund

The VC firm had last raised a $100-million second fund in 2016.


Business management solutions provider Osome raises $2m in Target Global-led round

According to an official statement, the funds will be used for product development and market expansion into Australia and Hong Kong.


SG-based AUM Biosciences raises $1.5m in seed funding to develop affordable oncology drugs

By 2019, AUM Biosciences will build a pipeline of three small molecule oncology assets designed to treat a broad range of Asia-prevalent tumour types.


Singapore’s Grab confirms $100m investment in SoftBank-backed OYO Hotels

OYO had earlier said it got commitments for $1 billion from its investors including SoftBank.